A Novel Clinical Grading Scale to Guide the Management of Crusted Scabies

PLoS Neglected Tropical Diseases

Volumn 7, Issue 9, 2013, Pages

  Davis, Joshua S ^a,b   McGloughlin, Steven ^b,c   Tong, Steven Y C ^a,b   Walton, Shelley F ^a,d   Currie, Bart J ^a,b  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b ROYAL DARWIN HOSPITAL   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF THE SUNSHINE COAST   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; BENZYL BENZOATE; C REACTIVE PROTEIN; IVERMECTIN; LACTIC ACID; PERMETHRIN; TEA TREE OIL; UREA;

ADULT; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; CLINICAL GRADING SCALE; DISEASE SEVERITY; FEMALE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SARCOPTES SCABIEI; SCABIES; SCORING SYSTEM;

ADULT; ANIMALS; ANTIPARASITIC AGENTS; AUSTRALIA; CLINICAL MEDICINE; FEMALE; HOSPITALIZATION; HUMANS; IVERMECTIN; LENGTH OF STAY; MALE; MIDDLE AGED; SARCOPTES SCABIEI; SCABIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84884687502     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002387     Document Type: Article

References (24)

1. Hengge UR, Currie BJ, Jager G, Lupi O, Schwartz RA, (2006) Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis 6: 769-779.
2. Holt DC, McCarthy JS, Carapetis JR, (2010) Parasitic diseases of remote Indigenous communities in Australia. Int J Parasitol 40: 1119-1126.
3. Hay RJ, Steer AC, Chosidow O, Currie BJ, (2013) Scabies: a suitable case for a global control initiative. Curr Opin Infect Dis 26: 107-109.
4. Gracey M, King M, (2009) Indigenous health part 1: determinants and disease patterns. Lancet 374: 65-75.
5. Indigenous health in Australia: unacceptable differences remain. Lancet 381: 1158.
6. Andrews RM, Kearns T, Connors C, Parker C, Carville K, et al. (2009) A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis 3: e554.
7. Walton SF, Pizzutto S, Slender A, Viberg L, Holt D, et al. (2010) Increased allergic immune response to Sarcoptes scabiei antigens in crusted versus ordinary scabies. Clin Vaccine Immunol 17: 1428-1438.
8. Walton SF, (2010) The immunology of susceptibility and resistance to scabies. Parasite Immunol 32: 532-540.
9. Roberts LJ, Huffam SE, Walton SF, Currie BJ, (2005) Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 50: 375-381.
10. Currie BJ, McCarthy JS, (2010) Permethrin and ivermectin for scabies. N Engl J Med 362: 717-725.
11. Scott GR, Chosidow O, (2011) European guideline for the management of scabies, 2010. Int J STD AIDS 22: 301-303.
12. Currie B, Huffam S, O'Brien D, Walton S, (1997) Ivermectin for scabies. Lancet 350: 1551.
13. Huffam SE, Currie BJ, (1998) Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis 2: 152-154.
14. Walton SF, McKinnon M, Pizzutto S, Dougall A, Williams E, et al. (2004) Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol. Arch Dermatol 140: 563-566.
15. Nofal A, (2009) Variable response of crusted scabies to oral ivermectin: report on eight Egyptian patients. J Eur Acad Dermatol Venereol 23: 793-797.
16. Alberici F, Pagani L, Ratti G, Viale P, (2000) Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies. Br J Dermatol 142: 969-972.
17. Espy PD, Jolly HW Jr, (1976) Norwegian scabies: occurrence in a patient undergoing immunosuppression. Arch Dermatol 112: 193-196.
18. Millard LG, (1977) Norwegian scabies developing during treatment with fluorinated steroid therapy. Acta Derm Venereol 57: 86-88.
19. Binic I, Jankovic A, Jovanovic D, Ljubenovic M, (2010) Crusted (Norwegian) scabies following systemic and topical corticosteroid therapy. J Korean Med Sci 25: 188-191.
20. Svecova D, Chmurova N, Pallova A, Babal P, (2009) Norwegian scabies in immunosuppressed patient misdiagnosed as an adverse drug reaction. Epidemiol Mikrobiol Imunol 58: 121-123.
21. Child FJ, Higgins EM, (1995) Cutaneous manifestations of non-HIV immunosuppression. Br J Hosp Med 54: 395-399.
22. Brites C, Weyll M, Pedroso C, Badaro R, (2002) Severe and Norwegian scabies are strongly associated with retroviral (HIV-1/HTLV-1) infection in Bahia, Brazil. AIDS 16: 1292-1293.
23. Bergman JN, Dodd WA, Trotter MJ, Oger JJ, Dutz JP, (1999) Crusted scabies in association with human T-cell lymphotropic virus 1. J Cutan Med Surg 3: 148-152.
24. Currie BJ, Harumal P, McKinnon M, Walton SF, (2004) First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 39: e8-12.